Table 3.
Cell Lines | IC20 (μg/mL) 1 | ||
---|---|---|---|
24 h | 48 h | 72 h | |
NCI-H1703 | 1.49 ± 0.08 | 1.72 ± 0.07 | 1.83 ± 0.07 |
SK-LU-1 | 1.87 ± 0.13 | 2.91 ± 0.87 | 3.46 ± 0.72 |
HLCSC | 1.88 ± 0.16 | 2.65 ± 0.10 | 2.91 ± 0.21 |
Cell Lines | IC50 (μg/mL) 2 | ||
24 h | 48 h | 72 h | |
NCI-H1703 | 2.90 ± 0.16 | 2.93 ± 0.13 | 2.95 ± 0.11 |
SK-LU-1 | 3.96 ± 0.27 | 4.54 ± 1.35 | 4.99 ± 1.04 |
HLCSC | 2.88 ± 0.24 | 2.80 ± 0.11 | 3.14 ± 0.23 |
Cell Lines | IC80 (μg/mL) 1 | ||
24 h | 48 h | 72 h | |
NCI-H1703 | 5.65 ± 0.30 | 5.01 ± 0.22 | 4.73 ± 0.17 |
SK-LU-1 | 8.41 ± 0.57 | 7.08 ± 2.11 | 7.19 ± 1.50 |
HLCSC | 4.41 ± 0.37 | 2.95 ± 0.11 | 3.38 ± 0.24 |
1 IC20/80 values were estimated using the formula , where F is the desired percentage of maximal inhibition, i.e., 20% or 80%, and H is hill slope/gradient of the non-linear regression curve. 2 IC50 data were based on mean values obtained from duplicated dose–response curves in two independent experiments.